Katie L. Bullinger
Papers
1
Total Citations
50
H-Index
1
About
Katie L. Bullinger is a leading clinical researcher in neuromodulation for drug-resistant epilepsy, with a particular focus on centromedian thalamic deep brain stimulation (CM-DBS). Her landmark single-center study, published in 2022 and garnering over 50 citations, systematically evaluated CM-DBS outcomes, demonstrating its particular efficacy in generalized epilepsies such as Lennox-Gastaut syndrome. This work has been instrumental in clarifying patient selection criteria and refining stimulation parameters, addressing a critical gap in the evidence for thalamic neuromodulation. Bullinger's contributions have directly shaped clinical practice by providing robust data on seizure reduction and quality-of-life improvements in this challenging patient population. Her research bridges the gap between experimental neuromodulation and real-world application, offering new hope for patients with otherwise intractable epilepsy.
Research Focus
Key Achievements
Top Papers
- 1